Addition/Correction Cite This: Chem. Mater. XXXX, XXX, XXX−XXX
pubs.acs.org/cm
Correction to Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations Feng Chen, Kai Ma, Miriam Benezra, Li Zhang, Sarah M. Cheal, Evan Phillips, Barney Yoo, Mohan Pauliah, Michael Overholtzer, Pat Zanzonico, Sonia Sequeira, Mithat Gonen, Thomas Quinn, Ulrich Wiesner,* and Michelle S. Bradbury* Downloaded via 95.85.71.38 on October 9, 2018 at 10:09:47 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.
Chem. Mater. 2017, 29 (20), 8766−8779. DOI: 10.1021/acs.chemmater.7b03033
W
e would like to correct the Conflict of Interest statement, which was “The authors declare no competing f inancial interest”, to “One or more US or international patent applications submitted by the authors relate to the radiolabeling, surface chemistry, characterization, and biomedical applications of the products. MSK, Cornell, and two investigators involved in this study have a financial interest in Elucida Oncology, Inc.”
■
AUTHOR INFORMATION
ORCID
Feng Chen: 0000-0001-6495-1030 Kai Ma: 0000-0003-4415-6894 Thomas Quinn: 0000-0001-5352-5335 Ulrich Wiesner: 0000-0001-6934-3755 Michelle S. Bradbury: 0000-0003-3147-4391 Notes
One or more US or international patent applications submitted by the authors relate to the radiolabeling, surface chemistry, characterization, and biomedical applications of the products. MSK, Cornell, and two investigators involved in this study have a financial interest in Elucida Oncology, Inc.
© 2017 American Chemical Society
A
DOI: 10.1021/acs.chemmater.8b04072 Chem. Mater. XXXX, XXX, XXX−XXX
